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Postural orthostatic tachycardia syndrome (POTS) is a chronic, multifactorial syndrome with 
complex symptoms of orthostatic intolerance. Breathlessness is a prevalent symptom, 
however little is known about the aetiology.  Anecdotal evidence suggests that breathless 
POTS patients commonly demonstrate dysfunctional breathing/hyperventilation syndrome 
(DB/HVS). There are, however, no published data regarding DB/HVS in POTS, and whether 
physiotherapy / breathing retraining may improve patients’ breathing pattern and symptoms.   
 
The aim of this study was to explore the potential impact of a physiotherapy intervention 
involving education and breathing control on DB/HVS in POTS. A retrospective observational 
cohort study of all patients with POTS referred to respiratory physiotherapy for treatment of 
DB/HVS over a 20-month period was undertaken.  
 
100 patients (99 female, mean (standard deviation) age 31 (12) years) with a clinical diagnosis 
of DB/ HV were referred, of which data was available for 66 patients pre – post intervention. 
Significant improvements in Nijmegen score, respiratory rate and breath hold time (seconds) 
were observed following treatment. These data provide a testable hypothesis that breathing 
retraining may provide breathless POTS patients with some symptomatic relief, thus 
improving their health-related quality of life.  The intervention can be easily protocolised to 
ensure treatment fidelity.  Our preliminary findings provide a platform for a subsequent 






Postural orthostatic tachycardia syndrome (POTS) is a chronic, multifactorial syndrome with 
complex symptoms of orthostatic intolerance.  POTS is defined as an increase in heart rate of 
≥30 bpm in adults (or by ≥40 bpm in children), within 10 minutes of standing, with no 
orthostatic fall in blood pressure [1].  
POTS is more common in women (5:1), especially those of child bearing age (15-50 years)[2]. 
Symptoms associated with POTS include: palpitations, light headedness/syncope, chest 
discomfort, breathlessness, neuropathic pain, chronic fatigue, poor sleep efficiency, 
gastrointestinal symptoms, syncope, cognitive slowing and psychological distress [3]. The 
symptom burden for patient with POTS can be high and very debilitating; impacting directly 
on patient’s health related quality of life [4, 5]. The functional impairment in patients with 
POTS has been compared to that of patients with congestive heart failure and chronic 
obstructive pulmonary disease (COPD)[6].  
Breathlessness is a common symptom in patients with POTS [7, 8]. Cohort studies suggest 
that ≥65% of patients experience significant breathlessness [9, 10] although little is known 
about the aetiology in this patient group. Although accurate numbers were not available, 
anecdotal evidence from our own hospital trust indicates approximately 80 - 90% of patients 
with POTS have some degree of DB/HVS.  Clinically, patients often attribute their 
breathlessness to changes in breathing pattern, frequency and / or quality of their breathing 
alongside cardiac symptoms such as tachycardia and / or palpitations. For many patients with 
POTS, their breathlessness can be episodic, triggered; by physical activity, stressful thoughts 
and events. 
Dysfunctional breathing (DB) is an umbrella term describing breathing disorders in which 
chronic changes in breathing pattern result in breathlessness and other symptoms in the 
absence or in excess of the magnitude of physiological respiratory or cardiac disease [11]. 
There is no consensus definition of dysfunctional breathing, or gold standard diagnostic 
criteria. The most widely recognised form of dysfunctional breathing is hyperventilation 
syndrome (HVS), which was first described over 70 years ago [12]. HVS remains the most 
extensively studied form of dysfunctional breathing. Hyperventilation syndrome is often also 
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used synonymously with dysfunctional breathing, whereas in fact it is just one type of 
breathing pattern disorder.  
 
Boulding and colleagues [11] suggest the following classification of dysfunctional 
breathing; 1) Hyperventilation syndrome: a respiratory pattern associated with symptoms 
both related to respiratory alkalosis and independent of hypocapnia. 2) Periodic deep sighing: 
frequent sighing with an irregular breathing pattern. 3) Thoracic dominant breathing: a 
respiratory pattern occurring separate to somatic disease may be considered dysfunctional 
and results in dyspnoea. 4) Forced abdominal expiration: inappropriate and excessive use of 
abdominal muscle contraction to aid expiration. 5) Thoraco-abdominal asynchrony: a 
respiratory pattern in which there is delay between rib cage and abdominal contraction 
resulting in ineffective breathing movements. DB is not a continuously symptomatic state but 
a syndrome of episodic symptoms that occur with or without recognisable provocation [11, 
13, 14]. 
In clinical practice, patients with POTS often undergo extensive investigations due to the 
complexity of potential comorbidities e.g. Ehlers - Danlos syndrome (EDS), chronic pain, 
fibromyalgia and symptoms e.g. chest pain, palpations, breathlessness, fatigue [30].  There is, 
however, no guidance or consensus as to which diagnostic test should be undertaken with 
respect to the assessment of breathlessness in these breathless patients. Anecdotal evidence 
suggests that breathless POTS patients commonly demonstrate DB/HVS in the absence of 
structural cardiac and / or respiratory disease [15].  
We have, therefore, taken a pragmatic approach to treatment of these patients within our 
NHS Foundation Trust and they are referred to Respiratory Physiotherapy for assessment and 
treatment. There are, to date, no published data regarding DB/HVS in POTS, nor the potential 
benefits that physiotherapy may have on improving patients’ breathing pattern and 
symptoms. 
The aim of this paper is, therefore, to describe 1) the physiotherapy treatment of DB/HVS in 






A retrospective, observational cohort study of all patients with POTS referred to respiratory 
physiotherapy for treatment of dysfunctional breathing and associated breathlessness 
between May 2015 and January 2017. 
 
Respiratory physiotherapy outpatient’s referral criteria 
 
Patients with POTS presenting with breathlessness were investigated using a pragmatic 
approach, within our hospital with the following tests: cardiopulmonary exercise testing, lung 
function testing, capillary blood gas and a hyperventilation provocation test.  A positive 
hyperventilation provocation test was defined as: end tidal carbon dioxide (etC02) at rest or 
10 minutes post voluntary hyperventilation < 4.3kPa. 
 
DB/HVS was identified on the cardiopulmonary exercise test if the following were observed; 
Hyperventilation was determined by an end-tidal CO2 (ETCO2) <4.0kPa in either the rest, 
unloaded or pre - anaerobic threshold (AT) parts of the test. Acute hyperventilation was 
recorded if the respiratory exchange ration (RER) was highly variable or ETCO2 rapidly 
normalised at the beginning of the exercise test when unloaded cycling began. Chronic 
hyperventilation was considered when RER was steady and remained low for a considerable 
period of the test. Although ventilatory equivalents for O2 and CO2 are also often elevated, 
the definition for hyperventilation is based on the ETCO2. 
Although difficult to establish, DFB was determined from examination of the ventilatory 
responses to exercise, with marked variability in minute ventilation (MV), tidal volume (VT) 
and respiratory rate (RR) considered to be the most robust diagnostic criteria (falls in excess 
of 5L/min in MV with swings in tidal volume and or respiratory rate).  Large swings in the 
ventilatory equivalents for both CO2 and O2 are also observed and reflect the varying 
efficiency of this breathing pattern. 
All patients referred to Respiratory Physiotherapy for assessment and treatment had been 
extensively reviewed by a Respiratory physician and a Cardiologist and referral based on 
clinical history, examination, lung function and cardiopulmonary exercise testing.  All patients 
had a positive hyperventilation provocation test, with significant breathlessness either at rest 
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or disproportionate breathlessness on exertion in the absence of any cardiac and / or 
respiratory, suggestive of DB/ HVS. 
Physiotherapy Assessment and Outcome Measures:  
 
A standardised physiotherapy assessment of patient symptoms was performed on all patients 
that included: a detailed subjective history including symptom prevalence (see figure 1), 
review of lung function tests, assessment of chest wall movement / breathing pattern and 
thoracic posture.  Symptom prevalence was quantified by asking patients to give yes / no 
answer with regards to having any of the symptoms summarised in figure 1.  
 
Assessment of chest wall movement / breathing pattern included: the manual assessment of 
respiratory motion (MARM), and/ or the Hi Lo breathing assessment [16], respiratory rate and 
breath hold time [16, 17]. MARM is a palpatory technique, with the patient in the seated 
position the examiner places their hands over the lower lateral rib cage, where they can 
assess thoracic expansion and the contribution of the upper thorax and lower 
thorax/abdomen[17]. 
 
The Hi Lo breathing assessment is another palpatory technique. With the patient in the sitting 
position, the physiotherapist places one hand on the sternum and one on the upper 
abdomen, to determine whether thoracic or abdominal motion is dominant and to assess for 
any paradoxical movement. Both MARM and Hi lo are well established clinical physiotherapy 
assessment techniques used to identify dysfunctional breathing patterns [17].  
Patients were asked to complete the Nijmegen questionnaire [18] at each attendance to 




The physiotherapy intervention was standardised with regards to both the educational 
component and breathing re-training exercises, which were reinforced using standardised 
written resources e.g. exercises instruction. A consultant physiotherapist or highly specialised 
respiratory physiotherapist delivered the intervention. Each patient was assessed and treated 
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to the point of discharge by the same physiotherapist.  The duration of the initial assessment 
and treatment session was 1 hour, with subsequent sessions lasting 30 minutes.  
 
Physiotherapy Treatment  
 
1. The educational component of the intervention focused on the patient’s 
understanding and consisted of:  
I. Respiratory physiology, specifically respiratory control and normal breathing pattern 
II. The mind – body link and how external factors such as anxiety, stress and lifestyle 
influences breathing patterns resulting in breathlessness [19] 
 
2. The breathing re-training intervention 
The breathing re-training method involved teaching breathing control. This approach aimed 
to achieve nasal breathing, a normal respiratory rate, tidal volume and inspiratory / expiratory 
ratio with appropriate thoraco-abdominal excursion. The technique is intended to provide 
patients with a feeling of being in control of their breathing pattern. Breathing control was 
initially taught with the patient in the supine position. Patients were advised to place one 
hand on their chest and the other on their abdomen, thereby providing feedback to the 
patient with regards to reducing any excessive upper chest movements (apical breathing).  
Patients were then guided thorough the breathing control exercise which involved breathing 
with an inspiratory time of two seconds, an expiratory time of two seconds and a post 
expiratory pause of one second (i.e. total respiratory cycle time = 5 seconds, with the aim of 
achieving a resting respiratory rate of 12 breaths per minute) [20-22].   If when teaching 
breathing control, patients were unable to reduce excessive upper chest movements, they 
were instructed to place both hands behind their head to help fix the upper chest and reduce 
upper chest motion. Patients were advised that if they were unable to sustain a normal resting 
respiratory rate (12 bpm) and pattern, or became anxious / experienced significant 
unpleasant symptoms that they should rest until the symptoms subsided and start again. 
Patients were instructed that the aim of the breathing exercise was to slowly and 
progressively increase tolerance of the imposed breathing pattern and rate. All patients were 




The breathing retraining exercise programme was standardised and progressive.  Once 
patients were proficient at undertaking the breathing control exercises in the supine position, 
they were progressed to performing the exercises while sitting and then onto more 
challenging / functional positions e.g. standing, walking as appropriate.  
 
As patients progressed to the seated posture, the controlled pause technique (exercise) was 
introduced.  The aim of this technique is to desensitise the patient to the ventilatory 
responses and symptoms associated with the small increases in carbon dioxide that occur 
when reducing respiratory rate and tidal volume[24]. Following a normal breath in and out 
patients were instructed to pinch their nose and hold their breath until the first signs of 
discomfort (air hunger) were experienced. Initially, patients were advised to perform the 
controlled pause in the supine position, 4 times a day and progressed to the sitting position 
as symptoms allowed.  Once this was achieved, patients were advised to combine controlled 
pause and breathing control i.e. undertake the controlled pause followed by a sustained 
period of breathing control [21-23]. 
 
All the treatments used in the intervention were standard respiratory physiotherapy 
techniques commonly applied to patients with acute and chronic respiratory disease [22, 25] 
their use in the context of breathless POTS patients has not been assessed previously. Patients 
were discharged from Physiotherapy, when a well-established daily physiotherapy breathing 
re-training programme had been established and patients were confident to continue the 
programme independently.  Patients that did not attend for follow up appointments were 

















All data were tested for normality using Shapiro-wilk normality testing. Demographic data are 
therefore expressed as mean (SD) as appropriate while Pre – post intervention outcome 
measures (Nijmegen score, respiratory rate and breath hold time) are expressed as median 
(range).  The significance of change in Nijmegen score, respiratory rate and breath hold time 
was assessed using non – parametric analysis; Wilcoxon matched pairs signed rank test results 
summarised in figure2, table 2 All statistical analysis was performed using Prism software 





Over the study period, 100 patients with POTS were referred for Physiotherapy assessment 
and treatment. All referred patients had a physiotherapy confirmed diagnosis of DB/HVS base 
on clinical assessment and a Nijmegen score >22 [18]. Patient demographics and 
characteristics are summarised in table 1. Breathlessness, most notably disproportionate 
breathlessness on exertion, was highly prevalent in this cohort (figure 1). Of those 100, pre – 
post physiotherapy data was available for 66 patients.  Eighteen patients failed to attend 
follow up appointments with acute illness, fatigue, burden of hospital attendances and travel 
distance being the main reasons for non-attendance.  There were no marked differences 
between those patients referred for treatment and completing the intervention (table 1). 
Sixteen patients were still undergoing treatment at the point that data analysis was 
undertaken and were therefore excluded from the pre – post physiotherapy data analysis.  
Significant improvements were observed pre – post physiotherapy in Nijmegen score, 
respiratory rate and breath hold time (figure 2, table 2). 97% of patients reported an 
improvement in symptom burden, quantified by a reduction in their Nijmegen Score, 3% of 
patient reported a minimal change ≤ 1 on the Nijmegen score.  23% of patient reported a 
Nijmegen score ≤ 22, after receiving the physiotherapy intervention. The mean (range) 
number of physiotherapy treatment sessions associated with these observed improvements 
were 3 (2- 8). 
11 
 
Table 1: Patient characteristics of all patients with a clinical diagnosis of POTS and DFB/ HV that were 1) 
referred and 2) completed the physiotherapy intervention. Data are presented as either mean (SD) or number 
of patients (%) 
 
* Documented diagnosis as per their clinical notes. 
 All patients referred for 
Physiotherapy (n=100) 
 
Patients that completed the 
Physiotherapy intervention (n =66) 
Age 31 (12) 32 (13) 
Sex  Female = 99, Male = 1 Female = 66, Male = 0 
BMI 24 (5) 24 (5) 
FEV1 (L) 3 (0.6) 3 (0.6) 
FEV1 % predicted 98 (13) 96 (13) 
VC (L) 4.4 (7) 5(9) 
VC % predicted 102 (13) 101 915) 
FEV1 / VC 82 (7) 81 (7) 
PEF 416 (70) 410 (67) 
PaO2 (kPa) 12.4 (1.3) 12.2 (1.1) 
PaCO2 (kPa) 4.5 (0.4) 4.4 (0.4) 
HCO3- 24 (1.4) 24 (1.3) 
pH 7.46 (0.06) 7.45 (0.03) 













Ehlers–Danlos syndrome (EDS)* 39 (39%) 27 (41%) 
Hypermobility syndrome* 19 (19%) 10 (15%) 
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Figure 2: Individual patient changes in (a) Nijmegen score, (b) respiratory rate and (c) breath hold time pre –post physiotherapy 
intervention. Each line represents an individual patient. 
 
 





Median of differences P Value 
Nijmegen score 37 (23 -51) 26 (6-46) -11 P<0.001 
Respiratory rate 22 (12 - 32) 18 (12 -24) -5 P<0.001 






This paper is the first to characterise dysfunctional breathing/hyperventilation syndrome 
(DB/HVS) in patients with POTS and to investigate the potential benefit of physiotherapy.  The 
results of this observational case series indicated that a physiotherapy intervention focused 
on breathing retraining for patients with POTS and dysfunctional breathing, resulted in 
significant improvements in breathing pattern and symptom burden as quantified by the 
Nijmegen questionnaire.  These data provide a testable hypothesis that breathing retraining 
may provide breathless POTS patients with some symptomatic relief, thus improving their 
health related quality of life.  The intervention can be easily protocolised to ensure treatment 
fidelity. The clinical and cost effectiveness of this potential intervention needs to be explored 
in a subsequent randomised controlled trial (RCT). 
 
 
Significance of the findings 
 
It is estimated that DB/HVS affects 10% of the general population and is more prevalent in 
women than in men [26].  Our data demonstrated that patients with POTS who reported 
significant breathlessness at rest or disproportionate breathlessness on exertion, and / or 
symptoms of air hunger, excessive yawing or sighing, had DB/HVS. DB/HVS may coexists 
alongside chronic respiratory diseases such as asthma [26, 27] and chronic obstructive 
pulmonary disease [28] although whether the relationship is causal or coincidental remains 
unclear. More frequently DB/HVS occurs in the absence of respiratory disease [13], in keeping 
with our data.   
 
Although the changes in the Nijmegen score, respiratory rate and breath hold time outcomes 
for the patient cohort as a whole were all statistically significant post intervention, it is clear 
from the range of values observed for each outcome measure that not all patients had 
complete resolution of their DB / HVS following treatment.  In addition it is possible that the 
improvement in breath hold time could have been due a training effect. The lack of an MCID 
for respiratory rate, breath hold time and Nijmegen limits the clinical interpretation of these 
observations. Patients were, however, discharged from this service only when they had a 
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well-established breathing re-training routine and felt confident that they could self-manage 
their DB/HVS and associated symptoms, supporting the finding that that the intervention 
positively impacted on patient’s symptom burden and self-management capabilities.  Future 
studies would undoubtably benefit from data on MCID of the outcome measures employed 
and should explore the long-term impact of this type of intervention. 
 
Unexplained breathlessness and ‘air hunger’ are the predominant symptoms of DB/HVS[29] 
and can result in significant patient morbidity and an array of non-respiratory symptoms 
including: chest tightness, dizziness, palpitations, pins and needles most noted in the feet, 
hands or around the mouth [22, 29]. The presence of these symptoms can themselves result 
in anxiety / panic, which can provoke further breathing irregularity.  
 
While orthostatic tachycardia is the hallmark of POTS, orthostasis also initiates increased 
minute ventilation and decreased end – tidal CO2 in many patients. Hyperpnea in POTS is 
related to sympathetic baroreflex stimulation and almost complete cardiovagal baroreflex 
withdrawal [24] resulting in hypocapnia. POTS patients have decreased central 
chemosensitivity  to CO2, but conversely peripheral chemosensitivity to hypoxia is enhanced 
[30].  It is hypothesised that enhanced hypoxic sensitivity may contribute to the long-term 
facilitation of sympathoexcitation in patients with POTS, resulting in chronic hyperventilation 
/ dysfunctional breathing patterns.  The hypocapnia resulting from chronic / intermittent 
hyperventilation (HV) reduces cerebral blood flow and contributes to light-headedness and 
to cognitive impairment during daily life. It also lowers the excitatory threshold for nerve 
fibres resulting in paraesthesia and reduces the Bohr effect so that haemoglobin releases 
oxygen less easily.  Acute-on-chronic HV results in a reduction in peripheral vascular 
resistance, and reduced mean arterial blood pressure (MAP). The reduced MAP exacerbates 
/ triggers POTS symptoms of light headiness and fainting, as well as increasing heart rate to 
compensate for the reduced venous return and lowered cardiac output, and maintain blood 
pressure [30, 31].   
 
It must be acknowledged that psychological influences such as stress, anxiety and depression, 
which are highly prevalent in patients with POTS [4, 5] predispose patients to DB/HVS. In our 
cohort approximately 50% of the patients had anxiety (figure1).  Given the high self – reported 
15 
 
prevalence of anxiety and depression in these patients, clinical services and future studies 
should consider including the GAD-7 anxiety [32] and the PHQ9 – Depression [33]. The impact 
of our intervention could be, therefore partly related to a change in anxiety achieved by 
education and greater understanding of DB / HVS in relation to POTS and also empowering 
patients to take control of their breathing pattern.  
 
Potentially, the observed change in symptoms such as the disproportionate breathlessness 
on exertion or air hunger, alongside increased breath – hold time may be underpinned by 
correction of hypocapnia.  As hypocapnia is relevant to both the pathophysiology of POTS and 
the cohort of patients studied. To test this hypothesis future studies should include pre – post 
PaC02 measurements [24].   
 
While it must be acknowledged that it can be difficult in some cases to exclude asthma 
without undertaking an airway challenge test, in the context of the current preliminary 
examination of a potential clinical intervention, it was neither feasible nor indicated to 
undertake provocation testing in all patients. It would be important, however, to precisely 
phenotype patients in any future large observational multi center studies or randomised 
controlled trials.   Any such diagnostic should include provocation testing, to exclude asthma 
and because of the presence of unexplained breathlessness a screening echocardiogram to 
exclude the possibility of pulmonary hypertension.  
 
Our paper suggests that screening for and treating DB/HVS in patients with POTS, reduces 
symptom burden; the challenge for clinical service provision is that the prevalence of POTS in 
the UK remains unknown. An interesting observation from our study is that nearly 20% of the 
patients that were assessed and found to have a DB / HVS failed to attend their follow up 
appointments. The lack of MCID for the selected the outcomes limited the analysis that could 
be performed with regards to any exploring factors that might be associated with patients 
failing to attend their follow up appointment. Given the age of these patients and building on 
the work of work of Burton et al, 2018 [21], a self – guided online breathing retraining 





The provision and access to respiratory physiotherapy outpatient services is limited across 
the NHS.  Many POTS patients are seen by musculoskeletal physiotherapy services due to the 
coexistence of hypermobility syndromes, chronic pain and chronic fatigue.  This paper 
highlights the importance of increasing awareness of DB/HVS in patients with POTS. This has 
wider implications beyond respiratory physiotherapy, as clinically the inclusion of a simple 
breathing retraining approach, alongside other physiotherapeutic interventions may facilitate 
greater or sustained improvements in physical function and or symptom control in these 
patients. 
The current data highlight the need to determine the prevalence of dysfunctional breathing 
in patients with POTS, and how this relates to other chronic conditions such as asthma.  
Alongside this, a core set of clinical investigational standards are also required to enable full 
phenotyping of patients with POTS and to help understand the factors that influence or 
predispose these patients to develop dysfunctional breathing patterns.  Finally, detailed 
assessment techniques and classification criteria, which clearly describe the nature of 
dysfunctional breathing patterns chronic hyperventilation, dysfunctional breathing without 
hyperventilation or a combination of both, are required. Addressing these unmet needs may 
help elucidate whether patients with POTS have a propensity for dysfunctional breathing or 
if such manifestations are a part of the syndrome itself. 
 
Limitations  
The data reported are from a service evaluation and hence no control data are available.  The 
improvements observed in patient status could have been due to increased contact with 
healthcare professionals rather than the treatment intervention.  These data should be 
therefore interpreted with caution. Our findings should be considered preliminary and 
provide a platform for a subsequent randomised controlled trial.   
A limitation of the current outcome measures (Nijmegen questionnaire, respiratory rate and 
breath hold time) is that they were validated against the hyperventilation provocation test 
and therefore potentially lack the specificity and sensitivity to detect changes in non – 
hyperventilation dysfunctional breathing patterns. Future studies may want to consider 
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techniques, such as structured light plethysmography, that can detect non-hyperventilatory 
dysfunctional breathing [34]. 
Due to the observational nature of this study and the small sample size, we were unable to 
explore the potential role of confounding variables such as pain, deconditioning and anxiety 
that may affect breathlessness intensity.  Applying a randomisation by minimisation approach 
using baseline Nijmegen score, anxiety score and performance status e.g. EQ5D would help 
address this issue. When planning future prospective studies, careful consideration will be 
required to fully characterise the breathless POTS patients enrolled and examine the response 
of different participant phenotypes to the intervention.  Such an approach would facilitate 
responder analysis. Methodologically, future studies may also benefit from using a 
randomised, controlled, delayed intervention model, which would address the issue of 
ensuring an appropriate control group.  In addition, a mixed methods approach would allow 
intervention acceptability, mechanism(s) of action and the impact on patients health related 
quality of life to be addressed  
The patient cohort included in this service evaluation exercise gained access to respiratory 
physiotherapy due the adoption of a pragmatic approach to treatment.  The treatment 
intervention was based on current evidence in the literature as well as clinical guidelines that 
advocate breathing re-training for dysfunctional breathing patterns that often co-exist with 
chronic respiratory disease such as asthma [21, 22]. This may have resulted in selection bias.  
This was a convenience sample drawn from patients who presented with breathlessness and 
were subsequently referred to respiratory physiotherapy and then attended.  Although 
limited, the prevalence data, suggests that breathlessness is a significant problem for patients 
with POTS, supporting the generalisability of these findings to the larger POTS population.  
The Nijmegen questionnaire is an established and acceptable outcome measure used within 
respiratory physiotherapy clinical practice [18, 28, 35, 36]. The Nijmegen score proved useful 
in characterising these patients, but it must be acknowledged that this tool has not been 
validated in this patient population. Given the considerable overlapping symptoms with DB / 
HVS and POTS, the diagnostic utility and sensitivity of the Nijmegen score in POTS needs to 
be evaluated.  Moreover, theses potential limitations of the Nijmegen score highlights the 
need for a holistic POTS specific patient reported outcome measure that focuses on symptom 
burden and health related quality of life.    
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While capillary blood gas and a hyperventilation provocation test the HV screen and EBGs 
provided a useful physiological outcome measure in the diagnosis of HVS, these are often 
limited to specialist services and therefore alternative diagnostic tests are sought. Recently, 
the Breathing Pattern Assessment Tool (BPAT) has demonstrated good sensitivity (0.92) and 
specificity (0.75) for the diagnosis of dysfunctional breathing in refractory asthma [27]. The 
BPAT is a novel method of quantifying respiratory pattern / function and may address the 
challenges of accessing 1) specialist physiological tests i.e. capillary blood gas and a 
hyperventilation provocation test /or 2) specialist respiratory physiotherapists to provide a 
clinical diagnosis of DFB/ HV. However, the responsiveness of the BPAT to treatment remains 
to be ascertained.  
 Measuring Neural Respiratory Drive (NRD) in breathlessness patients with POTS may be 
advantageous. NRD provides a global measure of respiratory function and a physiological 
correlate to breathlessness [37, 38] but, whether NRD is increased in POTS is unknown.  To 
date, there are no data exploring NRD pre – post respiratory interventions such as breathing 
retraining. Whether these observed improvements in respiratory function (respiratory rate 





In this physiotherapy intervention, which focused on breathing retraining for patients with 
POTS and dysfunctional breathing, significant improvements in symptoms, respiratory rate 
and breath hold time were observed following treatment. Although our findings are 
preliminary, they provide a platform for subsequent investigations and the potential for a 





Ethical approval was not required for this study as all patients were receiving routine care 
provided by King’s College Hospital NHS Foundation Trust.  Local approvals were obtained 
prior to undertaking this service evaluation. No funding was provided to undertake this 
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